Oceanside, California May 29, 2026 – EDERRA has announced the signing of a Letter of Intent (LOI) with Cepham, dated March 26, 2026, to establish a strategic manufacturing and production alliance aimed at bolstering EDERRA’s functional superfood range, notably its flagship formula, EMPWR+.
According to the LOI, the parties plan to finalize definitive agreements where Cepham will supply production and operational assistance. This support is designed to aid EDERRA in scaling manufacturing incrementally, improving sourcing and packaging processes, and speeding up product innovation.
This collaboration marks a pivotal moment in EDERRA’s growth from a new brand to a scalable wellness platform, driven by increasing demand for EMPWR+, a functional greens mix formulated to promote cellular detox and defense, gut health, cognitive function, and longevity.
EDERRA is utilizing an asset-light expansion strategy by collaborating with established scientific and manufacturing partners instead of developing internal manufacturing infrastructure. This model is favored by modern wellness companies looking to scale efficiently while upholding quality.
EDERRA’s brand is founded on a farm-to-body philosophy that links consumers directly to ingredient sourcing and transparency. Cepham offers extensive experience in nutraceutical ingredient development, manufacturing quality systems, and global supply chain management.
“Investors are currently backing execution engines, not just products,” stated Vladi Delsoglio, Founder and CEO of EDERRA. “This LOI is a significant stride toward creating a scalable operational foundation that aligns with our farm-to-body commitment. By leveraging Cepham’s science-first and operations-focused strategy, we intend to reduce supply risks, hasten disciplined production growth, and use capital more efficiently, allowing us to focus on driving demand and distribution.”
“EDERRA is creating a brand that views sourcing and transparency as essential product features,” commented Dr. Anand Swaroop, President of Cepham. “This approach is closely aligned with our dedication to safety, science, and sustainability. We are eager to pursue a partnership that helps EDERRA scale while maintaining the integrity, traceability, and quality standards that today’s consumers and discerning investors require from next-generation wellness firms.”
The agreement also underscores rising investor interest in the longevity economy, functional nutrition, and preventive health sectors, which are projected to see sustained growth as healthcare trends shift toward prevention and performance optimization.
As functional nutrition continues to merge the distinctions between supplements, food, and performance health, firms that can blend brand development, scientific validity, and operational scale are likely to lead the category in the coming decade.
“We are building a company intended to endure for decades, not merely follow fads,” Delsoglio added. “Execution is ultimately what differentiates brands that garner attention from those that establish categories.”
About EDERRA
EDERRA is a California-based functional wellness business creating superfood formulations centered on longevity, cognitive performance, gut health, and daily wellness optimization. Its primary product, EMPWR+, showcases the company’s farm-to-body philosophy, prioritizing ingredient transparency, sourcing integrity, and measurable functional benefits for modern wellness practices.
For more information, visit:
www.ederralyfe.com
About Cepham
Cepham is a U.S. nutraceutical firm specializing in the creation and production of evidence-based ingredients and delivery systems for the natural health market. The company’s expertise includes ingredient research and development, manufacturing, and global supply chain operations.
For more information, visit:
www.cepham.com
Forward-Looking Statements
This press release includes forward-looking statements regarding expectations, plans, and expected benefits related to the Letter of Intent and any potential definitive agreements. These statements are subject to risks and uncertainties, and actual results may differ materially from those projected. EDERRA is not obligated to update forward-looking statements unless required by law.
Media Contact
EDERRA
vladi@ederralyfe.com
https://ederralyfe.com/
Source :EDERRA
This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content.
Category: Top News, Daily News
SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.